Man Group PLC Werewolf Therapeutics, Inc. Transaction History
Man Group PLC
- $37.6 Billion
- Q2 2024
A detailed history of Man Group PLC transactions in Werewolf Therapeutics, Inc. stock. As of the latest transaction made, Man Group PLC holds 44,481 shares of HOWL stock, worth $91,186. This represents 0.0% of its overall portfolio holdings.
Number of Shares
44,481
Previous 79,639
44.15%
Holding current value
$91,186
Previous $516,000
79.07%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding HOWL
# of Institutions
79Shares Held
32.3MCall Options Held
53.8KPut Options Held
1.3K-
Ra Capital Management, L.P. Boston, MA6.14MShares$12.6 Million0.23% of portfolio
-
Mpm Asset Management LLC Cambridge, MA4.28MShares$8.78 Million6.25% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA3.24MShares$6.64 Million0.41% of portfolio
-
Bio Impact Capital LLC Cambridge, MA2.39MShares$4.9 Million0.79% of portfolio
-
Bank Of America Corp Charlotte, NC2.15MShares$4.4 Million0.0% of portfolio
About Werewolf Therapeutics, Inc.
- Ticker HOWL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,529,400
- Market Cap $60.5M
- Description
- Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional ...